In pathology, evaluating a tumor’s cellular architecture and, if necessary, selecting from amongst established diagnostic markers generally leads to a proper diagnosis. Interrogating a tumor’s underlying biology may confirm a suspected diagnosis – the sarcoma family of tumors serve as classic examples. Although uncommon, a new diagnosis is found after a thorough molecular evaluation of a tumor specimen, sometimes dramatically altering the course of management.